Developmental changes in gamma-glutamyl transpeptidase in human amniotic fluid

Area of Science:

• Biochemistry
• Developmental Biology
• Clinical Chemistry

Background:

• Human amniotic fluid contains gamma-glutamyl transpeptidase (GGT), an enzyme with clinical relevance.
• Previous studies have indicated variations in GGT properties, but developmental changes in amniotic fluid GGT remain underexplored.

Purpose of the Study:

• To investigate the molecular characteristics and developmental changes of human amniotic fluid gamma-glutamyl transpeptidase (GGT) during gestation.
• To elucidate the role of the carbohydrate moiety in these developmental alterations.

Main Methods:

• Gel chromatography (G-200) was used to assess the molecular weight of GGT.
• Concanavalin A-Sepharose binding was employed to evaluate carbohydrate interactions.
• Cellulose acetate electrophoresis was performed to determine electrophoretic mobility.
• Enzymatic treatments with papain and neuraminidase were utilized to probe structural modifications.

Main Results:

• Amniotic fluid GGT exists in a high molecular weight form, reducible to approximately 98,000 Da after papain treatment.
• Early amniotic fluid GGT predominantly binds to Concanavalin A and exhibits alpha-mobility.
• Late amniotic fluid GGT is largely non-reactive with Concanavalin A and shows beta-mobility.
• Neuraminidase treatment normalized the electrophoretic mobility differences between early and late GGT forms.
• Papain treatment did not affect GGT's electrophoretic mobility or Concanavalin A binding.

Conclusions:

• The carbohydrate moiety of human amniotic fluid GGT undergoes significant developmental modifications throughout gestation.
• These changes in glycosylation patterns influence GGT's molecular properties, including Concanavalin A binding and electrophoretic mobility.
• Understanding these transformations provides insights into fetal development and the role of GGT in the amniotic environment.